<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Merck.com - Company Statements</title>
<link>http://www.merck.com/newsroom/company-statements/</link>
<description>Merck.com - Company Statements</description>
<image>
	<title>Merck.com - Company Statements</title>
	<width>142</width>
	<height>42</height>
	<link>http://www.merck.com/newsroom/company-statements/</link>
	<url>http://www.merck.com/site_images/mercklogo-rss.jpg</url>
</image>
<item>
	<title>The Supreme Court of Canada Will Not Review the Saskatchewan Court of Appeal Judgment Overturning a Class Certification Order in VIOXX® Action </title>
	<guid isPermaLink="false">MerckUpdatesStat10/22/2009</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/corporate/2009_1022.html?src=rss</link>
	<pubDate>Thu, 22 Oct 2009 00:00:00 GMT</pubDate>
</item>
<item>
	<title>Merck Statement on U.S. Speaker Fees Company Achieves another Milestone in Its Ongoing Transparency Initiative</title>
	<guid isPermaLink="false">MerckStatementon10/19/2009</guid>
	<link>http://www.merck.com/newsroom/company-statements/2009_1019.html?src=rss</link>
	<pubDate>Mon, 19 Oct 2009 00:00:00 GMT</pubDate>
</item>
<item>
	<title>Merck Statement About JANUVIA&amp;reg; (sitagliptin) and JANUMET&amp;reg; (sitagliptin/metformin)</title>
	<guid isPermaLink="false">New,LongTermData09/25/2009</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/product/2009_0925.html?src=rss</link>
	<pubDate>Fri, 25 Sep 2009 00:00:00 GMT</pubDate>
</item>
</channel>
</rss>